Zum Inhalt wechseln
Zum Inhalt wechseln

Stoffbewertung - CoRAP

Stoffbewertung - CoRAP

If a substance is on this list, it means that a Member State has evaluated or will evaluate it over the coming years. The list is called the Community rolling action plan (CoRAP).

For each substance, the table shows the evaluating Member State, the (planned) year of evaluation and a short description of the concern which led to it being placed on the list.

Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information.  Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.

 

Notes to the Substance Evaluation table
  • Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
  • The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
  • When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
  • When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
  • Contact details of the evaluating Member States are provided for all the substance included.
  • Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.

Legend:

Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
RCR: Risk Characterisation Ratio 

Last updated 24 August 2016. Database contains 319 unique substances/entries.
Filter the list

 
EC No. 216-133-4 and EC No. 244-240-6
show/hide
1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthyl)ethan-1-one EC / List no.: 216-133-4 | CAS no.: 1506-02-1
1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthyl)ethan-1-one EC / List no.: 244-240-6 | CAS no.: 21145-77-7
-
-
Germany
High (aggregated) tonnage
Potential endocrine disruptor
Not started
Details
-
-
Germany
Consumer use
Cumulative exposure
Exposure of environment
Exposure of workers
Suspected Carcinogenic
Wide dispersive use
Not started
Details
-
-
Germany
Suspected PBT/vPvB
Exposure of environment
Not started
Details
EC No. 415-490-5 and 604-250-7
-
-
Germany
Suspected PBT/vPvB
Wide dispersive use
Exposure of environment
Ongoing
Details
200-001-8
50-00-0
France
CMR
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
200-076-7
51-03-6
Sweden
Consumer use
Potential endocrine disruptor
Suspected PBT/vPvB
Wide dispersive use
Not started
Details
200-262-8
56-23-5
France
CMR
Exposure of workers
High (aggregated) tonnage
Information requested
Details
200-657-5
67-51-6
Spain
High RCR
Reprotoxic
Not started
Details
200-659-6
67-56-1
Poland
Consumer use
Exposure of environment
Exposure of workers
Suspected CMR
Wide dispersive use
Concluded
Details
200-752-1
71-41-0
Lithuania
Suspected Sensitiser
Wide dispersive use
Consumer use
Exposure of workers
High RCR
Ongoing
Details
200-817-4
74-87-3
Italy
CMR
Potential endocrine disruptor
High RCR
Information requested
Details
200-838-9
75-09-2
Italy
Carcinogenic
High (aggregated) tonnage
Potential endocrine disruptor
Suspected Mutagenic
Suspected Reprotoxic
Suspected Sensitiser
Ongoing
Details
200-843-6
75-15-0
France
CMR
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Potential endocrine disruptor
Information requested
Details
200-849-9
75-21-8
Austria
CMR
High (aggregated) tonnage
Concluded
Details
200-889-7
75-65-0
United Kingdom
Consumer use
High (aggregated) tonnage
High RCR
Suspected CMR
Wide dispersive use
Information requested
Details
200-901-0
75-78-5
Czech Republic
High (aggregated) tonnage
Suspected PBT/vPvB
Concluded
Details
201-052-9
77-73-6
France
Suspected Reprotoxic
Exposure of workers
High RCR
High (aggregated) tonnage
Ongoing
Details
201-126-0
78-59-1
France
CMR
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
201-180-5
79-14-1
Belgium
Consumer use
Exposure of sensitive populations
Exposure of workers
High (aggregated) tonnage
Reprotoxic
Wide dispersive use
Not started
Details
201-202-3
79-39-0
Sweden
Other hazard based concern
Exposure of workers
Ongoing
Details
201-222-2
79-74-3
United Kingdom
High RCR
Suspected PBT/vPvB
Information requested
Details
201-236-9
79-94-7
Denmark
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Potential endocrine disruptor
Suspected PBT/vPvB
Suspected Reprotoxic
Wide dispersive use
Ongoing
Details
201-245-8
80-05-7
Germany
Potential endocrine disruptor
Wide dispersive use
Consumer use
High (aggregated) tonnage
Information requested
Details
201-247-9
80-07-9
Austria
Suspected PBT/vPvB
Wide dispersive use
High (aggregated) tonnage
Not started
Details
201-248-4
80-08-0
Germany
Potential endocrine disruptor
Ongoing
Details
201-250-5
80-09-1
Belgium
High (aggregated) tonnage
Potential endocrine disruptor
Suspected CMR
Information requested
Details
201-279-3
80-43-3
Norway
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Suspected PBT/vPvB
Wide dispersive use
Ongoing
Details
201-280-9
80-46-6
Germany
Consumer use
Potential endocrine disruptor
Wide dispersive use
Information requested
Details
201-289-8
80-54-6
Sweden
CMR
Wide dispersive use
Consumer use
Information requested
Details
201-297-1
80-62-6
France
Sensitiser
Wide dispersive use
Consumer use
Exposure of sensitive populations
High RCR
High (aggregated) tonnage
Ongoing
Details
201-550-6
84-66-2
Germany
Consumer use
CMR
High (aggregated) tonnage
Potential endocrine disruptor
Wide dispersive use
Concluded
Details
201-618-5
85-60-9
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Wide dispersive use
Exposure of environment
Consumer use
Exposure of workers
Not started
Details
201-983-0
90-30-2
Germany
Suspected PBT/vPvB
Wide dispersive use
Information requested
Details
202-046-9
91-17-8
Finland
Suspected PBT/vPvB
High (aggregated) tonnage
Information requested
Details
202-049-5
91-20-3
United Kingdom
Exposure of workers
High (aggregated) tonnage
High RCR
Other exposure/risk based concern
Ongoing
Details
202-112-7
91-97-4
France
Consumer use
Sensitiser
Suspected CMR
Suspected PBT/vPvB
Information requested
Details
202-163-5
92-52-4
Portugal
High (aggregated) tonnage
Suspected PBT/vPvB
Information requested
Details
202-307-7
94-13-3
Belgium
Consumer use
Exposure of environment
Exposure of sensitive populations
Potential endocrine disruptor
Suspected Reprotoxic
Wide dispersive use
Ongoing
Details
202-394-1
95-14-7
Germany
Potential endocrine disruptor
Exposure of environment
Ongoing
Details
202-422-2
95-47-6
Germany
Consumer use
Cumulative exposure
High (aggregated) tonnage
High RCR
Suspected CMR
Suspected Sensitiser
Wide dispersive use
Ongoing
Details
202-423-8
95-48-7
United Kingdom
Suspected Mutagenic
Not started
Details
202-425-9
95-50-1
Hungary
High (aggregated) tonnage
Suspected CMR
Wide dispersive use
Information requested
Details
202-496-6
96-29-7
Germany
Consumer use
Cumulative exposure
CMR
High RCR
Sensitiser
Wide dispersive use
Concluded
Details
202-510-0
96-49-1
Latvia
Suspected Reprotoxic
Other hazard based concern
Wide dispersive use
Consumer use
Exposure of workers
High (aggregated) tonnage
Not started
Details
202-525-2
96-69-5
Austria
Consumer use
Potential endocrine disruptor
Sensitiser
Suspected CMR
Suspected PBT/vPvB
Wide dispersive use
Ongoing
Details
202-532-0
96-76-4
Belgium
Consumer use
Potential endocrine disruptor
Suspected CMR
Wide dispersive use
Not started
Details
202-597-5
97-63-2
Italy
Suspected CMR
Sensitiser
Wide dispersive use
Consumer use
High (aggregated) tonnage
Ongoing
Details
202-626-1
98-00-0
Poland
Consumer use
CMR
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
202-653-9
98-29-3
Poland
Suspected Mutagenic
Sensitiser
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of environment
Exposure of workers
Not started
Details
202-679-0
98-54-4
Germany
High (aggregated) tonnage
Potential endocrine disruptor
Information requested
Details

Export search results to:

Damit Sie die Website optimal nutzen können, verwenden wir Cookies.

Weitere Informationen über unsere Verwendung von Cookies.

Die ECHA bietet zahlreiches Online-Material in Ihrer Sprache an, ein Teil dieser Seite liegt jedoch nur auf Englisch vor. Mehr über die Praxis der Mehrsprachigkeit bei der ECHA.
Diese Nachricht nicht mehr anzeigen.